Cytokine involvement in stress may depend on corticotrophin releasing factor to sensitize ethanol withdrawal anxiety

Brain, Behavior, and Immunity

Volumn 25, Issue SUPPL. 1, 2011, Pages

  Knapp, Darin J ^a   Whitman, Buddy A ^a   Wills, Tiffany A ^a   Angel, Robert A ^a   Overstreet, David H ^a   Criswell, Hugh E ^a   Ming, Zhen ^a   Breese, George R ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Alcohol; Amygdala; Corticotrophin releasing factor receptor; Cytokine; Electrophysiology; Ethanol; SL327; SSR125543; Stress; TNF

Indexed keywords

4 (2 CHLORO 4 METHOXY 5 METHYLPHENYL) N [2 CYCLOPROPYL 1 (3 FLUORO 4 METHYLPHENYL)ETHYL] 5 METHYL N (2 PROPYNYL) 2 THIAZOLAMINE; ALPHA [AMINO(4 AMINOPHENYLTHIO)METHYLENE] 2 (TRIFLUOROMETHYL)PHENYLACETONITRILE; CORTICOSTERONE; CORTICOTROPIN RELEASING FACTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

4 AMINOBUTYRIC ACID RELEASE; ALCOHOL WITHDRAWAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; CENTRAL NUCLEUS (AMYGDALA); CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; MALE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN INTERACTION; RAT; SENSITIZATION; STRESS;

ADAPTATION, PSYCHOLOGICAL; ALCOHOLS; AMYGDALA; ANALYSIS OF VARIANCE; ANIMALS; ANXIETY; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; CYTOKINES; ELECTROPHYSIOLOGY; ETHANOL; HYDROCARBONS, HALOGENATED; MALE; MICROINJECTIONS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RESTRAINT, PHYSICAL; STRESS, PHYSIOLOGICAL; SUBSTANCE WITHDRAWAL SYNDROME; THIAZINES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79955714682     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2011.02.018     Document Type: Article

References (77)

1. Adler M., Geller E., Chen X., Rogers T. Viewing chemokines as a third major system of communication in the brain. AAPS J. 2006, 7:E865-870.
2. Alfonso-Loeches S., Pascual-Lucas M., Blanco A.M., Sanchez-Vera I., Guerri C. Pivotal role of TLR4 receptors in alcohol-induced neuroinflammation and brain damage. J. Neurosci. 2010, 30(24):8285-8295.
3. Anisman H., Merali Z., Hayley S. Sensitization associated with stressors and cytokine treatments. Brain Behav. Immun. 2003, 17(2):86-93.
4. Anisman H., Merali Z. Cytokines, stress and depressive illness: brain-immune interactions. Ann. Med. 2003, 35(1):2-11.
5. Bajetto A., Bonavia R., Barbero S., Schettini G. Characterization of chemokines and their receptors in the central nervous system: physiopathological implications. J. Neurochem. 2002, 82(6):1311-1329.
6. Bauer S., Kerr B.J., Patterson P.H. The neuropoietic cytokine family in development, plasticity, disease and injury. Nat. Neurosci. Rev. 2007, 8(3):221-232.
7. Borsody, M.K., Weiss, J.M. 2002-2003. Alteration of locus coeruleus neuronal activity by interleukin-1 and the involvement of endogenous corticotropin-releasing hormone. Neuroimmunomodulation 10(2), 101-121.
8. Brady K.T., Lydiard R.B. The association of alcoholism and anxiety. Psychiatr. Quart. 1993, 64(2):135-149.
9. Breese G.R., Overstreet D.H., Knapp D.J. Stress sensitization of the alcohol withdrawal-induced reduction in social interaction: inhibition by CRF-1 and benzodiazepine receptor antagonists and a 5-HT1A agonist. Neuropsychopharmacology 2004, 29(3):470-482.
10. Breese G.R., Overstreet D.H., Knapp D.J. Conceptual framework for the etiology of alcoholism: a " kindling" /stress hypothesis. Psychopharmacology (Berl) 2005, 178(4):367-380.
11. Breese G.R., Overstreet D.H., Knapp D.J., Navarro M. Prior multiple ethanol withdrawals enhance stress-induced anxiety-like behavior: inhibition by CRF1- and benzodiazepine-receptor antagonists and a 5-HT1a-receptor agonist. Neuropsychopharmacology 2005, 30(9):1662-1669.
12. Breese G.R., Knapp D.J., Overstreet D.H., Navarro M., Wills T.A., Angel R.A. Repeated lipopolysaccharide (LPS) or cytokine treatments sensitize ethanol withdrawal-induced anxiety-like behavior. Neuropsychopharmacology 2008, 33(4):867-876.
13. Breese G.R., Sinha R., Heilig M. Chronic alcohol neuroadaptation and stress contribute to susceptibility for alcohol craving and relapse. Pharmacol. Ther. 2011, 129(2):149-171.
14. Deak T., Bordner K., McElderry N., Barnum C., Blandino P., Deak M., Tammariello S. Stress-induced increases in hypothalamic IL-1: systematic analysis of multiple stressor paradigms. Brain Res. Bull. 2005, 64:541-556.
15. del Cerro S., Borrrell J. Interleukin-1 affects the behavioral despair response in rats by an indirect mechanism which requires endogenous CRF. Brain Res. 1990, 528(1):162-164.
16. Dolganiuc A., Bakis G., Kodys K., Mandrekar P., Szabo G. Acute ethanol treatment modulates Toll-like receptor-4 association with lipid rafts. Alcohol. Clin. Exp. Res. 2006, 30(1):76-85.
17. Dunn A.J., Swiergiel A.H., de Beaurepaire R. Cytokines as mediators of depression: what can we learn from animal studies?. Neurosci. Biobehav. Rev. 2005, 29(4-5):891-909.
18. File S.E., Hyde J.R. Can social interaction be used to measure anxiety?. Br. J. Pharmacol. 1978, 62(1):19-24.
19. File S.E., Seth P. A review of 25 years of the social interaction test. Eur. J. Pharmacol. 2003, 463(1-3):35-53.
20. Fox H.C., Bergquist K.L., Hong K.I., Sinha R. Stress-induced and alcohol cue-induced craving in recently abstinent alcohol-dependent individuals. Alcohol. Clin. Exp. Res. 2007, 31(3):395-403.
21. Frank M.G., Miguel Z.D., Watkins L.R., Maier S.F. Prior exposure to glucocorticoids sensitizes the neuroinflammatory and peripheral inflammatory responses to E. coli lipopolysaccharide. Brain Behav. Immun. 2010, 24(1):19-30.
22. Gallagher J.P., Orozco-Cabal L.F., Liu J., Shinnick-Gallagher P. Synaptic physiology of central CRH system. Eur. J. Pharmacol. 2008, 583(2-3):215-225.
23. Hains L.E., Loram L.C., Weiseler J.L., Frank M.G., Bloss E.B., Sholar P., Taylor F.R., Harrison J.A., Martin T.J., Eisenach J.C., Maier S.F., Watkins L.R. Pain intensity and duration can be enhanced by prior challenge: initial evidence suggestive of a role of microglial priming. J. Pain 2010, 11(10):1004-1014.
24. Hauger R.L., Risbrough V., Brauns O., Dautzenberg F.M. Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets. CNS Neurol. Disord. Drug Targets 2006, 5:453-479.
25. Hauger R.L., Risbrough V., Oakley R.H., Olivares-Reyes J.A., Dautzenberg F.M. Role of CRF receptor signaling in stress vulnerability, anxiety, and depression. Ann. N. Y. Acad. Sci. 2009, 1179:120-143.
26. Hayley S., Poulter M.O., Merali Z., Anisman H. The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity. Neuroscience 2005, 135(3):659-678.
27. He J., Crews F.T. Increased MCP-1 and microglia in various regions of the human alcoholic brain. Exp. Neurol. 2008, 210(2):349-358.
28. Heilig M., Koob G.F. A key role for corticotropin-releasing factor in alcohol dependence. Trends Neurosci. 2007, 30(8):399-406.
29. Huang M.M., Overstreet D.H., Knapp D.J., Angel R.A., Wills T.A., Navarro M., Rivier J., Vale W.W., Breese G.R. Corticotropin-releasing factor (CRF) sensitization of ethanol withdrawal-induced anxiety-like behavior is brain site specific and mediated by CRF-1 receptors: relation to stress-induced sensitization. J. Pharmacol. Exp. Ther. 2010, 332(1):298-307.
30. Jara J.H., Singh B.B., Floden A.M., Combs C.K. Tumor necrosis factor alpha stimulates NMDA receptor activity in mouse cortical neurons resulting in ERK-dependent death. J. Neurochem. 2007, 100(5):1407-1420.
31. Johnson J.D., O'Connor K.A., Watkins L.R., Maier S.F. The role of IL-1beta in stress-induced sensitization of proinflammatory cytokine and corticosterone responses. Neuroscience 2004, 127(3):569-577.
32. Jung H., Toth P.T., White F.A., Miller R.J. Monocyte chemoattractant protein-1 functions as a neuromodulator in dorsal root ganglia neurons. J. Neurochem. 2008, 104(1):254-263.
33. Kawasaki Y., Zhang L., Cheng J.K., Ji R.R. Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord. J. Neurosci. 2008, 28(20):5189-5194.
34. Knapp D.J., Overstreet D.H., Breese G.R. Modulation of ethanol withdrawal-induced anxiety-like behavior during later withdrawals by treatment of early withdrawals with benzodiazepine/gamma-aminobutyric acid ligands. Alcohol. Clin. Exp. Res. 2005, 29(4):553-563.
35. Knapp D.J., Overstreet D.H., Angel R.A., Navarro M., Breese G.R. The amygdala regulates the antianxiety sensitization effect of flumazenil during repeated chronic ethanol or repeated stress. Alcohol. Clin. Exp. Res. 2007, 31(11):1872-1882.
36. Kohman R.A., Tarr A.J., Sparkman N.L., Day C.E., Paquet A., Akkaraju G.R., Boehm G.W. Alleviation of the effects of endotoxin exposure on behavior and hippocampal IL-1beta by a selective non-peptide antagonist of corticotropin-releasing factor receptors. Brain Behav. Immun. 2007, 21(6):824-835.
37. Koob G.F. Brain stress systems in the amygdala and addiction. Brain Res. 2009, 1293:61-75.
38. Koob G.F. The role of CRF and CRF-related peptides in the dark side of addiction. Brain Res. 2010, 1314:3-14.
39. Kreutzberg G.W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 1996, 19(8):312-318.
40. Lowery E.G., Thiele T.E. Pre-clinical evidence that corticotropin-releasing factor (CRF) receptor antagonists are promising targets for pharmacological treatment of alcoholism. CNS Neurol. Disord. Drug Targets 2010, 9(1):77-86.
41. Minami M., Kuraishi Y., Yamaguchi T., Nakai S., Hirai Y., Satoh M. Immobilization stress induces interleukin-1 beta mRNA in the rat hypothalamus. Neurosci. Lett. 1991, 123(2):254-256.
42. Munhoz C.D., Sorrells S.F., Caso J.R., Scavone C., Sapolsky R.M. Glucocorticoids exacerbate lipopolysaccharide-induced signaling in the frontal cortex and hippocampus in a dose-dependent manner. J. Neurosci. 2010, 30(41):13690-13698.
43. Nguyen K.T., Deak T., Owens S.M., Kohno T., Fleshner M., Watkins L.R., Maier S.F. Exposure to acute stress induces brain IL-1β protein in the rat. J. Neurosci. 1998, 18(6):2239-2246.
44. O'Connor K.A., Johnson J.D., Hansen M.K., Wieseler Frank J.L., Maksimova E., Watkins L.R., Maier S.F. Peripheral and central proinflammatory cytokine response to a severe acute stressor. Brain Res. 2003, 991(1-2):123-132.
45. Overstreet D.H., Knapp D.J., Breese G.R. Accentuated decrease in social interaction in rats subjected to repeated ethanol withdrawals. Alcohol. Clin. Exp. Res. 2002, 6(8):1259-1268.
46. Overstreet D.H., Knapp D.J., Moy S.S., Breese G.R. A 5-HT1A agonist and a 5-HT2c antagonist reduce social interaction deficit induced by multiple ethanol withdrawals in rats. Psychopharmacology (Berl.) 2003, 167(4):344-352.
47. Overstreet D.H., Knapp D.J., Breese G.R. Modulation of multiple ethanol withdrawal-induced anxiety-like behavior by CRF and CRF1 receptors. Pharmacol. Biochem. Behav. 2004, 77(2):405-413.
48. Overstreet D.H., Knapp D.J., Angel R.A., Navarro M., Breese G.R. Reduction in repeated ethanol-withdrawal-induced anxiety-like behavior by site-selective injections of 5-HT1A and 5-HT2C ligands. Psychopharmacology (Berl.) 2006, 187(1):1-12.
49. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 2005, Elsevier Academic Press, Burlington, MA.
50. Pérez-Nievas B.G., Madrigal J.L., García-Bueno B., Zoppi S., Leza J.C. Corticosterone basal levels and vulnerability to LPS-induced neuroinflammation in the rat brain. Brain Res. 2010, 1315:159-168.
51. Plata-Salaman, C.R., Borkoski, J.P., (1994). Chemokines/intercrines and central regulation of feeding. Am. J. Physiol. 266(Part 2), R1711-R1715.
52. Plata-Salaman C.R., Sonti G., Borkoski J.P., Wilson C.D., French-Mullen J.M. Anorexia induced by chronic central administration of cytokines at estimated pathophysiological concentrations. Physiol. Behav. 1996, 60:867-875.
53. Pohorecky L.A. Stress and alcohol interaction: an update of human research. Alcohol. Clin. Exp. Res. 1991, 15(3):438-459.
54. Pohorecky L.A. The interaction of alcohol and stress. A review. Neurosci. Biobehav. Rev. 1981, 5(2):209-229.
55. Pucak M.L., Kaplin A.l. Unkind cytokines: current evidence for the potential role of cytokines in immune-mediated depression. Int. Rev. Psychiatry 2005, 17(6):477-483.
56. Qin L., He J., Hanes R.N., Pluzarev O., Hong J.S., Crews F.T. Increased systemic and brain cytokine production and neuroinflammation by endotoxin following ethanol treatment. J. Neuroinflam. 2008, 5:10.
57. Raison C.L., Capuron L., Miller A.H. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006, 27(1):24-31.
58. Regier D.A., Farmer M.E., Rae D.S., Locke B.Z., Keith S.J., Judd L.L., Goodwin F.K. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the epidemiologic catchment area (ECA) study. JAMA 1990, 264(19):2511-2518.
59. Rostène W., Kitabgi P., Parsadaniantz S.M. Chemokines: a new class of neuromodulator?. Nat. Rev. Neurosci. 2007, 8(11):895-903.
60. Shi P., Raizada M.K., Sumners C. Brain cytokines as neuromodulators in cardiovascular control. Clin. Exp. Pharmacol. Physiol. 2010, 37(2):e52-57.
61. Shintani F., Nakaki T., Kanba S., Kato R., Asai M. Role of interleukin-1 in stress responses. A putative neurotransmitter. Mol. Neurobiol. 1995, 10(1):47-71.
62. Shizuya, K., Komori, T., Fujiware, R., Miyahara, S., Ohmori, M., Nomura, J., (1997). The influence of restraint stress on the expression of mRNAs for IL-6 and the IL-6 receptor in the hypothalamus and midbrain of the rat. Life Sci. 61(10), PL 135-140.
63. Sinha R., Li C.S. Imaging stress- and cue-induced drug and alcohol craving: association with relapse and clinical implications. Drug Alcohol Rev. 2007, 26(1):25-31.
64. Sinha R., Fox H.C., Hong K.A., Bergquist K., Bhagwagar Z., Siedlarz K.M. Enhanced negative emotion and alcohol craving, and altered physiological responses following stress and cue exposure in alcohol dependent individuals. Neuropsychopharmacology 2009, 34(5):1198-1208.
65. Smith R.J., Aston-Jones G. Noradrenergic transmission in the extended amygdala: role in increased drug-seeking and relapse during protracted drug abstinence. Brain Struct. Funct. 2008, 213(1-2):43-61.
66. Suzuki E., Shintani F., Kanba S., Asai M., Nakaki T. Immobilization stress increases mRNA levels of interleukin-1 receptor antagonist in various rat brain regions. Cell. Mol. Neurobiol. 1997, 17(5):557-562.
67. Szabo G., Dolganiuc A., Dai Q., Pruett S.B. TLR4, ethanol, and lipid rafts: a new mechanism of ethanol action with implications for other receptor-mediated effects. J. Immunol. 2007, 178(3):1243-1249.
68. Turnbull A.V., Rivier C.L. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol. Rev. 1999, 79(1):1-71.
69. Uddin M., Aiello A.E., Wildman D.E., Koenen K.C., Pawelec G., de Los Santos R., Goldmann E., Galea S. Epigenetic and immune function profiles associated with posttraumatic stress disorder. Proc. Natl. Acad. Sci. 2010, 107(20):9470-9475.
70. Valdez G.R., Roberts A.J., Chan K., Davis H., Brennan M., Zorrilla E.P., Koob G.F. Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence. Regulation by corticotropin-releasing factor. Alcohol. Clin. Exp. Res. 2002, 26(10):1494-1501.
71. Wang W., Ji P., Dow K.E. Corticotrophin-releasing hormone induces proliferation and TNF-alpha release in cultured rat microglia via MAP-kinase signalling pathways. J. Neurochem. 2003, 84:189-195.
72. Wang W., Ji P., Riopelle R.J., Dow K.E. Functional expression of corticotrophin-releasing hormone (CRH) receptor 1 in cultured rat microglia. J. Neurochem. 2002, 80(2):287-294.
73. Wilkinson M.F., Mathieson W.B., Pittman Q.J. Interleukin-1β has excitatory effects on neurons of the BNST. Brain Res. 1993, 625:342-346.
74. Wills T.A., Knapp D.J., Overstreet D.H., Breese G.R. Differential dietary ethanol intake and blood ethanol levels in adolescent and adult rats: effects on anxiety-like behavior and seizure thresholds. Alcohol. Clin. Exp. Res. 2008, 32(8):1350-1360.
75. Wills T.A., Knapp D.J., Overstreet D.H., Breese G.R. Sensitization, duration, and pharmacological blockade of anxiety-like behavior following repeated ethanol withdrawal in adolescent and adult rats. Alcohol. Clin. Exp. Res. 2009, 33(3):455-463.
76. Zhang Z., Morse A.C., Koob G.F., Schulteis G. Dose- and time-dependent expression of anxiety-like behavior in the elevated plus-maze during withdrawal from acute and repeated intermittent ethanol intoxication in rats. Alcohol. Clin. Exp. Res. 2007, 31(11):1811-1819.
77. Zhu W., Zheng H., Shao X., Wang W., Yao Q., Li Z. Excitotoxicity of tnfalpha derived from KA activated microglia on hippocampal neurons in vitro and in vivo. J. Neurochem. 2010, 114(2):386-396.